Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million Jan 23, 2026 09:16AM
Cardiol Therapeutics raises $13.5 million in bought deal financing Jan 16, 2026 08:43AM
Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million Jan 16, 2026 08:42AM
Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 45th Annual Growth Conference Aug 11, 2025 07:27AM
Cardiol Therapeutics Announces Exercise and Closing of Over-Allotment Option Oct 11, 2024 08:39AM


Oct 10, 2024 09:09AM Cardiol Therapeutics Announces Closing of US$13.5 Million Public Offering of Common Shares
Oct 9, 2024 08:01AM Cardiol Therapeutics (CRDL) Announces Pricing of Public Offering of Common Shares
Oct 9, 2024 07:58AM Cardiol Therapeutics Announces Pricing of Public Offering of Common Shares
Oct 8, 2024 04:03PM Cardiol Therapeutics (CRDL) Files Preliminary Prospectus Supplement for Proposed Share Offering
Oct 8, 2024 04:01PM Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Common Shares
May 23, 2024 06:53AM Cardiol Therapeutics (CRDL) PT Raised to $8 at Canaccord Genuity
Aug 9, 2023 07:27AM Cardiol Therapeutics to Present at Canaccord Genuity 43rd Annual Growth Conference
Jun 9, 2022 04:06PM Cardiol Therapeutics (CRDL) Announces At-The-Market Equity Offering Program
Jun 9, 2022 04:05PM Cardiol Therapeutics Announces At-The-Market Equity Offering Program
Apr 18, 2022 07:18AM Cardiol Therapeutics (CRDL) PT Lowered to $7 at Canaccord Genuity
Dec 3, 2021 07:17AM Canaccord Genuity Starts Cardiol Therapeutics (CRDL) at Buy
Nov 5, 2021 09:18AM Cardiol Therapeutics Announces Closing of US$50 Million Public Offering